Search research articles
Contact Us
Filters
Showing results (51-60 of 148) with videos related to
Page
of 15
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
May 23, 2003
A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer
Francesca M Buffa, Glenn D Flux, Matt J Guy, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
February 26, 2020
Linking CHHiP prostate cancer RCT with GP records: A study proposal to investigate the effect of co-morbidities and medications on long-term symptoms and radiotherapy-related toxicity
Agnieszka Lemanska, Rachel C Byford, Ana Correa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 27, 2007
Outcome of early detection and radiotherapy for occult spinal cord compression
Ramachandran Venkitaraman, Yolanda Barbachano, David P Dearnaley, et al.
The British Journal of Radiology
|
January 3, 2018
Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy
Ana M Denis-Bacelar, Sarah J Chittenden, V Ralph McCready, et al.
European Urology
|
December 20, 2008
A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance
Nicholas J van As, Nandita M de Souza, Sophie F Riches, et al.
European Urology
|
March 12, 2013
Medium-term outcomes of active surveillance for localised prostate cancer
Elizabeth D Selvadurai, Mausam Singhera, Karen Thomas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 22, 2005
The impact of introducing intensity modulated radiotherapy into routine clinical practice
Elizabeth A Miles, Catharine H Clark, M Teresa Guerrero Urbano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 5, 2006
Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397)
Stephen A Mangar, Matthew R Sydes, Helen L Tucker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 5, 2021
Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study
Miguel R Ferreira, Caroline J Sands, Jia V Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 30, 2004
Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397)
W Philip M Mayles, A Rollo Moore, Edwin G A Aird, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 148) with videos related to
Sort By:
Page
of 15
European Journal of Nuclear Medicine and Molecular Imaging
|
May 23, 2003
A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer
Francesca M Buffa, Glenn D Flux, Matt J Guy, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
February 26, 2020
Linking CHHiP prostate cancer RCT with GP records: A study proposal to investigate the effect of co-morbidities and medications on long-term symptoms and radiotherapy-related toxicity
Agnieszka Lemanska, Rachel C Byford, Ana Correa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 27, 2007
Outcome of early detection and radiotherapy for occult spinal cord compression
Ramachandran Venkitaraman, Yolanda Barbachano, David P Dearnaley, et al.
The British Journal of Radiology
|
January 3, 2018
Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy
Ana M Denis-Bacelar, Sarah J Chittenden, V Ralph McCready, et al.
European Urology
|
December 20, 2008
A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance
Nicholas J van As, Nandita M de Souza, Sophie F Riches, et al.
European Urology
|
March 12, 2013
Medium-term outcomes of active surveillance for localised prostate cancer
Elizabeth D Selvadurai, Mausam Singhera, Karen Thomas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 22, 2005
The impact of introducing intensity modulated radiotherapy into routine clinical practice
Elizabeth A Miles, Catharine H Clark, M Teresa Guerrero Urbano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 5, 2006
Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397)
Stephen A Mangar, Matthew R Sydes, Helen L Tucker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 5, 2021
Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study
Miguel R Ferreira, Caroline J Sands, Jia V Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 30, 2004
Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397)
W Philip M Mayles, A Rollo Moore, Edwin G A Aird, et al.
Page
of 15